Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor ActivityJonathan D. Graves, Pamela M. Holland, Tammy L. Bush et al.|Cancer Cell|2014Cited by 155
SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the CytoplasmKevin J. Hamblett, William C. Fanslow, Allison P. Jacob et al.|Cancer Research|2015Cited by 135